Health Care Cost
Eslicarbazepine acetate adjunctive therapy reduces charges related to focal seizures
Methamphetamine-related HF hospitalization ‘insidious yet rapidly growing’
Methamphetamine-related HF hospitalizations and their costs increased at an alarming rate compared with all HF hospitalization from 2008 to 2018, researchers reported.
Negative impact of medical expenses high among patients with ASCVD, cancer
Difficulty paying medical bills, financial stress, cost-related nonadherence and other financial toxicities were highly prevalent among patients with atherosclerotic CVD compared with those with cancer, researchers reported.
Highly refractory status epilepticus associated with worse outcomes, high hospital costs
Status epilepticus incurred “a large burden” on patients and the U.S. health care system over a 3-year study of more than 43,000 hospitalizations, with higher mortality risk and hospital costs as disease refractoriness increased.
Fewer hospitalizations, but higher total health costs 1 year after CGM initiation
People with type 1 diabetes in Israel had fewer hospitalizations with high adherence to continuous glucose monitoring 1 year after starting to use the device, but also experienced higher total health costs, according to study data.
Existing suicide risk prediction models may be cost-effective in health care settings
Existing suicide risk prediction models appeared sufficiently accurate to be cost-effective in United States health care settings, according to results of an economic evaluation published in JAMA Psychiatry.
Requesting generic drugs could save Medicare program $1.7 billion
By substituting branded drugs requested by prescribers for generic versions, Medicare could have saved $997 million and patients could have saved $161 million in 2017, according to research published in JAMA Network Open.
Long-term antithyroid drugs effective therapy for Graves’ disease
Long-term use of antithyroid drugs can be a viable alternative to ablative therapies for the management of Graves’ disease, according to a review article published in Clinical Endocrinology.
Endocrine Society outlines policy options to expand insulin access
The Endocrine Society is advocating for a suite of policy changes to expand access to insulin, including government negotiation of drug prices, limiting price increases and eliminating rebates, according to a new position statement.